SCIENTIFIC HUB

Follow the evidence.

SCIENTIFIC LITERATURE · PPR

Automated Histological Assessment of Parkinson’s Disease Models via Integrated Dopaminergic Neuron Segmentation and Phenotypic Quantification

· 2026-07-15

DOI: 10.21203/rs.3.rs-10278708/v1

Check source for accessPreprintOriginal source ↗

Research overview

The text below is the source article’s original abstract under a verified reuse license. cc by

Abstract Accurate quantification of dopaminergic neurons and their phenotypic state is essential for understanding neurodegeneration and evaluating therapeutic efficacy in Parkinson’s disease models. Traditional approaches, such as stereological counting, are labor-intensive and limited to structural assessment, while most automated methods neglect key biochemical markers like Tyrosine Hydroxylase (TH), a critical indicator of dopaminergic identity and viability. To overcome the limitations of existing methods that either focus solely on morphological segmentation or lack integrated biochemical analysis, a novel dual-head transformer-based architecture, SegDAFormer, is introduced in this research. It is specifically designed to jointly perform accurate dopaminergic neuron segmentation and fine-grained, pixel-wise quantification of TH expression from high-resolution histological images, thereby unifying structural and phenotypic assessment within a single, biologically interpretable framework. The model integrates a Hierarchical Transformer Encoder with a Multi-Scale Integrative Module, enabling effective fusion of local and global contextual features. Evaluated on a real TH-stained dataset, SegDAFormer achieves a Dice score of 93.12 ± 1.08%, counting error of 5.82 ± 1.45%, and TH intensity prediction error of MAE 7.96 ± 1.22, significantly outperforming existing baselines. Moreover, visual overlays confirm that predicted intensity maps reflect biologically meaningful gradients in neuronal phenotype. By bridging structural and biochemical analysis in a unified, interpretable framework, SegDAFormer advances automated histological assessment and holds strong potential for scalable applications in neurodegenerative research, drug screening, and digital pathology.

Scientific assessment

01

Research question

Assess the question within the original study’s scope.

02

Methods & sample

Check the source article for study design and sample details.

03

Key findings

An editorially approved findings summary is not yet published for this record.

04

Limitations

Generalizability, bias and clinical meaning require separate assessment.

Methods, samples and clinical conclusions are not inferred from bibliographic metadata.